STAT3 and cancer: The increase in p-STAT3 (Tyr705) in the nucleus subsequently initiates downstream signaling pathways, including the Hippo and Notch pathways in cancer cells, the VEGF pathway in endothelial cells and the PI3K-AKT pathway in T cells (Figure 7).